NovaBridge Biosciences reported an initial statement of beneficial ownership filed by Fu Wei, a director. The filing listed indirect holdings of 11,784,164 ordinary shares through CBC Investment l-Mab. It also reported indirect holdings of 7,129,885 ordinary shares through Nova Aqua. Fu Wei reported three employee share options covering 1.64 million, 2.45 million, and 2.45 million ordinary shares, each with an exercise price of USD 3.19.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-114829), on March 18, 2026, and is solely responsible for the information contained therein.